RJA
BSX icon

Ross\Johnson & Associates’s Boston Scientific BSX Stock Holding History

Ross\Johnson & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171 Buy
4
+1
+33% +$54 ﹤0.01% 241
2026
Q1 		$188 Sell
3
-2
-40% -$160 ﹤0.01% 171
2025
Q4 		$477 Buy
5
+2
+67% +$196 0.01% 163
2025
Q3 		$293 Hold
3
– – 0.01% 152
2025
Q2 		$322 Hold
3
– – 0.01% 137
2025
Q1 		$302 Buy
+3
New +$302 0.01% 286

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ross\Johnson & Associates's BSX Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $54 and bringing the position to 4 shares worth $171. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Ross\Johnson & Associates first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $477 in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ross\Johnson & Associates held 4 shares of Boston Scientific worth $171 as of Q2 2026.
  • Ross\Johnson & Associates bought 1 Boston Scientific share in Q2 2026, an estimated $54.
  • Boston Scientific made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #241 holding.
  • Ross\Johnson & Associates first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Boston Scientific position peaked at $477 in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.